September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
September 2026
The global genomics in cancer care market size was evaluated at USD 28.32 billion in 2026 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
September 2026
The global cell and gene therapy market size was calculated at USD 10.44 billion in 2026 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
September 2026
The global lung cancer diagnostics market size is estimated at USD 5.69 billion in 2026 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
September 2026
The photothermal therapy patches market size stood at USD 295.83 billion in 2026, with major photothermal therapy patches market companies including Photothermal Therapeutics Inc., NanoHybrids Inc., BioCure Technology Inc.
September 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 42.02 billion in 2026 with a notable CAGR of 5.95%.
September 2026
The global shock wave therapy market size is calculated at USD 2.57 billion in 2026 and is projected to hit around USD 6.48 billion by 2035 with a CAGR of 10.82%.
September 2026
The global radiotherapy market size is calculated at USD 9.10 billion in 2026 and is projected to hit around USD 15.56 billion by 2035 with a CAGR of 6.16%.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 268.17 billion in 2026, with a CAGR of 11.26%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.73 billion in 2026 with a CAGR of 7.31%.
September 2026
The neoantigen cancer vaccine market was worth USD 551.46 million in 2026, with key neoantigen cancer vaccine market players including Moderna Inc, BioNTech SE.
September 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
September 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
September 2026
The active pharmaceutical ingredients CDMO market reached USD 125.99 billion in 2026, with key active pharmaceutical ingredients CDMO market companies including Lonza, Thermo Fisher Scientific.
September 2026
The global aromatherapy market size surpassed USD 11.10 billion in 2026 and is estimated to reach around USD 23.31 billion by 2035, expanding at a CAGR of 8.61%.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.84 billion in 2026 with a notable CAGR of 5.66%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com